New York State Common Retirement Fund Silverback Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 41,703 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,703
Previous 12,107
244.45%
Holding current value
$0
Previous $103,000
487.38%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SBTX
# of Institutions
164Shares Held
62.7MCall Options Held
872KPut Options Held
589K-
Deerfield Management Company, L.P. (Series C) New York, NY11.1MShares$00.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...